Catry Boudewijn, Latour Katrien, Jans Béatrice, Vandendriessche Stien, Preal Ragna, Mertens Karl, Denis Olivier
Healthcare-Associated Infections & Antimicrobial Resistance, Public Health & Surveillance, Scientific Institute of Public Health, Brussels (WIV-ISP), Belgium.
Laboratoire de Référence MRSA - Staphylocoques, Department of Microbiology, Hôpital Erasme, ULB, Brussels, Belgium.
PLoS One. 2014 Feb 26;9(2):e89579. doi: 10.1371/journal.pone.0089579. eCollection 2014.
The present study aimed to investigate the dose response relationship between the prescriptions of antimicrobial agents and infection/colonization with methicillin resistant Staphylococcus aureus (MRSA) taking additional factors like stay in a health care facility into account.
Multi-centre retrospective study on a cohort of patients that underwent microbiological diagnostics in Belgium during 2005. The bacteriological results retrieved from 17 voluntary participating clinical laboratories were coupled with the individual antimicrobial consumption patterns (July 2004-December 2005) and other variables as provided by pooled data of health insurance funds. Multivariate analysis was used to identify risk factors for MRSA colonization/infection.
A total of 6844 patients of which 17.5% died in the year 2005, were included in a logistic regression model. More than 97% of MRSA was associated with infection (clinical samples), and only a minority with screening/colonization (1.59%). Factors (95% CI) significantly (p≤<0.01) associated with MRSA in the final multivariate model were: admission to a long term care settings (2.79-4.46); prescription of antibiotics via a hospital pharmacy (1.30-2.01); age 55+ years (3.32-5.63); age 15-54 years (1.23-2.16); and consumption of antimicrobial agent per DDD (defined daily dose) (1.25-1.40).
The data demonstrated a direct dose-response relationship between MRSA and consumption of antimicrobial agents at the individual patient level of 25-40% increased risk per every single day. In addition the study indicated an involvement of specific healthcare settings and age in MRSA status.
本研究旨在探讨抗菌药物处方与耐甲氧西林金黄色葡萄球菌(MRSA)感染/定植之间的剂量反应关系,并考虑诸如在医疗机构住院等其他因素。
对2005年在比利时接受微生物诊断的一组患者进行多中心回顾性研究。从17个自愿参与的临床实验室获取的细菌学结果与个体抗菌药物消费模式(2004年7月至2005年12月)以及医疗保险基金汇总数据提供的其他变量相结合。采用多变量分析来确定MRSA定植/感染的危险因素。
共有6844例患者纳入逻辑回归模型,其中2005年有17.5%的患者死亡。超过97%的MRSA与感染(临床样本)相关,仅有少数与筛查/定植相关(1.59%)。在最终的多变量模型中,与MRSA显著相关(p≤0.01)的因素(95%置信区间)为:入住长期护理机构(2.79 - 4.46);通过医院药房开具抗生素(1.30 - 2.01);年龄55岁及以上(3.32 - 5.63);年龄15 - 54岁(1.23 - 2.16);以及每定义日剂量(DDD)的抗菌药物消费量(1.25 - 1.40)。
数据表明,在个体患者层面,MRSA与抗菌药物消费之间存在直接的剂量反应关系,每天风险增加25% - 40%。此外,研究表明特定的医疗环境和年龄与MRSA状况有关。